Atezolizumab y bevacizumab en carcinoma hepatocelular irresecable / Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma
Gastroenterol. latinoam
;
32(1): 24-32, 2021. tab
Article
in Spanish
| LILACS
| ID: biblio-1352385
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Carcinoma, Hepatocellular
/
Antibodies, Monoclonal, Humanized
/
Bevacizumab
/
Liver Neoplasms
Limits:
Humans
Language:
Spanish
Journal:
Gastroenterol. latinoam
Journal subject:
Gastroenterology
Year:
2021
Type:
Article
Affiliation country:
Chile
Institution/Affiliation country:
Pontificia Universidad Católica de Chile/CL
Similar
MEDLINE
...
LILACS
LIS